- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Radiation Oncology 12 (2017).
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2017
- Urheber
-
Krauze, Andra V.
Attia, Albert
Braunstein, Steve
Chan, Michael
Combs, Stephanie
Fietkau, Rainer
Fiveash, John
Flickinger, John
Grosu, Anca
Howard, Steven
Nieder, Carsten
Niyazi, Karim-Maximilian
Rowe, Lindsay
Smart, Dee Dee
Tsien, Christina
Camphausen, Kevin
- URN
-
urn:nbn:de:bvb:29-opus4-93423
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krauze, Andra V.
- Attia, Albert
- Braunstein, Steve
- Chan, Michael
- Combs, Stephanie
- Fietkau, Rainer
- Fiveash, John
- Flickinger, John
- Grosu, Anca
- Howard, Steven
- Nieder, Carsten
- Niyazi, Karim-Maximilian
- Rowe, Lindsay
- Smart, Dee Dee
- Tsien, Christina
- Camphausen, Kevin
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2017
Ähnliche Objekte (12)
Expert consensus on re-irradiation for recurrent glioma
Radiotherapy for recurrent medulloblastoma in children and adolescents: survival after re-irradiation and first-time irradiation
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Assessment of the cortisol awakening response : Expert consensus guidelines
Transcriptional CDK inhibitors CYC065 and THZ1 induce apoptosis in glioma stem cells derived from recurrent GBM
Targeting the glioma associated microenvironment in experimental glioma
Knockdown of the TP53-induced glycolysis and apoptosis regulator (TIGAR) sensitizes glioma cells to hypoxia, irradiation and temozolomide
Expert consensus on re-irradiation for recurrent glioma
Radiotherapy for recurrent medulloblastoma in children and adolescents: survival after re-irradiation and first-time irradiation
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Assessment of the cortisol awakening response : Expert consensus guidelines
Transcriptional CDK inhibitors CYC065 and THZ1 induce apoptosis in glioma stem cells derived from recurrent GBM
Targeting the glioma associated microenvironment in experimental glioma
Knockdown of the TP53-induced glycolysis and apoptosis regulator (TIGAR) sensitizes glioma cells to hypoxia, irradiation and temozolomide
Expert consensus on re-irradiation for recurrent glioma
Radiotherapy for recurrent medulloblastoma in children and adolescents: survival after re-irradiation and first-time irradiation
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiation
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Assessment of the cortisol awakening response : Expert consensus guidelines
Transcriptional CDK inhibitors CYC065 and THZ1 induce apoptosis in glioma stem cells derived from recurrent GBM
Targeting the glioma associated microenvironment in experimental glioma